Summary
Few data regarding the use of cyclosporin A (CyA) in pregnancy are available and those available refer mainly to transplant recipients and not to patients with connective tissue diseases. We report the case of a patient with systemic lupus erythematosus (SLE), taking CyA before, during and after her pregnancy at a dose of 4 mg/kg per day. CyA was effective in controlling SLE activity and no side effects were obseved in mother or baby. The lack of teratogenicity in this case was in keeping with previous reports in experimental systems, animals and human transplant recipients. If our observation is confirmed by further studies, CyA might become useful in the treatment of pregnant patients with SLE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Roubenoff R, Hoyt J, Petri M, Hocheberg MC, Hellmann DB (1988) Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum 18:88–110
Cockburn I, Krupp P, Monka C (1989) Present experience of Sandimmun in pregnancy. Transplant Proc 21:3730–3732
Calne RY, White DJG, Tiru S, Evans DB, McMaster P, Dunn DL, Craddock GN, Pentlow BD, Rolles K (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet II:1323–1327
Schindler R (1985) Cyclosporin in autoimmune diseases. Springer, Berlin Heidelberg New York
Miescher PA, Favre H, Mihatsch MJ, Chatelanat F, Huang YP, Zubler R (1988) The place of Cyclosporin A in the treatment of connective tissue diseases. Transplant Proc 20[Suppl 4]:224–237
Zwanenburg TSB, Suter W, Matter BE (1988) Absence of genotoxic potential for cyclosporine in experimental system. Transplant Proc 20 [Suppl 2]:931–933
Ryffel B, Donatsch P, Mandorin M, Matter BE, Ruttimann G, Schon H, Stoll R, Wilson J (1983) Toxicological evaluation of cyclosporin A. Arch Toxicol 53:107–141
Sakaguchi S, Sakaguchi N (1989) Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol 142:471–480
Parfrey NA, Prud'homme GJ (1990) Patterns of MHC antigenic modulation in cyclosporine-induced autoimmunity. Implications for pathogenesis. Am J Pathol 136:479–486
Wright S, Glover M, Baker H (1991) Psoriasis, cyclosporine, and pregnancy (letter). Arch Dermatol 127:426
Lockshin MD (1985) Lupus pregnancy. Clin Rheum Dis 11:611–633
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Doria, A., Di Lenardo, L., Vario, S. et al. Cyclosporin A in a pregnant patient affected with systemic lupus erythematosus. Rheumatol Int 12, 77–78 (1992). https://doi.org/10.1007/BF00300981
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00300981